Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TERAZOSIN 5 MG CAPSULE

Terazosin
$0.1133per EA

Strength

5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135046090

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TERAZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075614

On Market Since

4/30/2021

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price History

1W

0.0%

1M

-3.0%

3M

-9.1%

6M

-8.0%

1Y

-21.1%

3Y

-29.6%

5Y

N/A

All

-29.2%

Generic Alternatives

1 alternative • Same active ingredient

TERAZOSIN 5 MG CAPSULE
Generic
69452033232•Bionpharma Inc.
$0.1133

Related Drugs

Same classification

CARVEDILOL 3.125 MG TABLET
Generic
00093005101•Teva Pharmaceuticals USA Inc.
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
00093005105•Teva Pharmaceuticals USA Inc.
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
00781522101•Sandoz Inc.
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
00904730561•Major Pharmaceuticals
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
65862014201•Aurobindo Pharma Limited
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
65862014205•Aurobindo Pharma Limited
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
68001015300•BluePoint Laboratories
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
68001015303•BluePoint Laboratories
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
68382009201•Zydus Pharmaceuticals (USA) Inc.
$0.0172
per EA
CARVEDILOL 3.125 MG TABLET
Generic
68382009205•Zydus Pharmaceuticals (USA) Inc.
$0.0172
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy